# Filing Detail

Form 8-K - Current report:
SEC Accession No. 0001193125-20-200676
Filing Date
2020-07-28
Accepted
2020-07-28 11:36:22
Documents
41
Period of Report
2020-07-28
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq | Description | Document | Type | Size
--- | --- | --- | --- | ---
1 | 8-K | d92144d8k.htm | 8-K | 30514
2 | EX-99.1 | d92144dex991.htm | EX-99.1 | 46017
3 | GRAPHIC | g92144ex99_1s10g1.jpg | GRAPHIC | 300575
4 | GRAPHIC | g92144ex99_1s11g1.jpg | GRAPHIC | 361011
5 | GRAPHIC | g92144ex99_1s12g1.jpg | GRAPHIC | 398957
6 | GRAPHIC | g92144ex99_1s13g1.jpg | GRAPHIC | 304490
7 | GRAPHIC | g92144ex99_1s14g1.jpg | GRAPHIC | 263293
8 | GRAPHIC | g92144ex99_1s15g1.jpg | GRAPHIC | 388777
9 | GRAPHIC | g92144ex99_1s16g1.jpg | GRAPHIC | 365367
10 | GRAPHIC | g92144ex99_1s17g1.jpg | GRAPHIC | 344895
11 | GRAPHIC | g92144ex99_1s18g1.jpg | GRAPHIC | 270412
12 | GRAPHIC | g92144ex99_1s19g1.jpg | GRAPHIC | 359855
13 | GRAPHIC | g92144ex99_1s1g1.jpg | GRAPHIC | 400799
14 | GRAPHIC | g92144ex99_1s20g1.jpg | GRAPHIC | 310629
15 | GRAPHIC | g92144ex99_1s21g1.jpg | GRAPHIC | 318205
16 | GRAPHIC | g92144ex99_1s22g1.jpg | GRAPHIC | 413948
17 | GRAPHIC | g92144ex99_1s23g1.jpg | GRAPHIC | 415191
18 | GRAPHIC | g92144ex99_1s24g1.jpg | GRAPHIC | 287033
19 | GRAPHIC | g92144ex99_1s25g1.jpg | GRAPHIC | 336078
20 | GRAPHIC | g92144ex99_1s26g1.jpg | GRAPHIC | 255079
21 | GRAPHIC | g92144ex99_1s27g1.jpg | GRAPHIC | 306349
22 | GRAPHIC | g92144ex99_1s28g1.jpg | GRAPHIC | 334801
23 | GRAPHIC | g92144ex99_1s29g1.jpg | GRAPHIC | 448466
24 | GRAPHIC | g92144ex99_1s2g1.jpg | GRAPHIC | 922722
25 | GRAPHIC | g92144ex99_1s30g1.jpg | GRAPHIC | 371625
26 | GRAPHIC | g92144ex99_1s31g1.jpg | GRAPHIC | 390514
27 | GRAPHIC | g92144ex99_1s32g1.jpg | GRAPHIC | 233426
28 | GRAPHIC | g92144ex99_1s33g1.jpg | GRAPHIC | 350152
29 | GRAPHIC | g92144ex99_1s34g1.jpg | GRAPHIC | 381649
30 | GRAPHIC | g92144ex99_1s35g1.jpg | GRAPHIC | 408416
31 | GRAPHIC | g92144ex99_1s36g1.jpg | GRAPHIC | 308206
32 | GRAPHIC | g92144ex99_1s37g1.jpg | GRAPHIC | 316688
33 | GRAPHIC | g92144ex99_1s38g1.jpg | GRAPHIC | 320800
34 | GRAPHIC | g92144ex99_1s39g1.jpg | GRAPHIC | 388016
35 | GRAPHIC | g92144ex99_1s3g1.jpg | GRAPHIC | 753780
36 | GRAPHIC | g92144ex99_1s4g1.jpg | GRAPHIC | 438870
37 | GRAPHIC | g92144ex99_1s5g1.jpg | GRAPHIC | 349065
38 | GRAPHIC | g92144ex99_1s6g1.jpg | GRAPHIC | 311113
39 | GRAPHIC | g92144ex99_1s7g1.jpg | GRAPHIC | 335761
40 | GRAPHIC | g92144ex99_1s8g1.jpg | GRAPHIC | 226986
41 | GRAPHIC | g92144ex99_1s9g1.jpg | GRAPHIC | 252744
| Complete submission text file | 0001193125-20-200676.txt |  | 19701849

Mailing Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116
Business Address 500 BOYLSTON STREET 12TH FLOOR BOSTON MA 02116 617-482-2333
resTORbio, Inc. (Filer) CIK: 0001720580 (see all company filings)

EIN.: 813305277 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38359 | Film No.: 201052482
SIC: 2834 Pharmaceutical Preparations